Disclosed positions

Estimated from their latest filings — positions may have changed since

$10.09M

combined est. value

Stock	Shares	Price	Value	Weight	As of
AUPHAurinia Pharmaceuticals Inc.	621,402	$16.23	$10.09M	100%	2026-05-18

AUPH

Aurinia Pharmaceuticals Inc.

$10.09M

621,402 sh

All filings on record

Every Form 4 transaction we track for this filer

all 6buys 0sells 0

Stock	Transaction	Date	~6mo later
AUPHAurinia Pharmaceuticals Inc.	Grant — · 115,541 sh	2026-05-18	—
AUPHAurinia Pharmaceuticals Inc.	Tax $519.0K · 36,525 sh	2026-03-02	—
AUPHAurinia Pharmaceuticals Inc.	Grant — · 59,090 sh	2026-02-27	—
AUPHAurinia Pharmaceuticals Inc.	Tax $498.8K · 34,638 sh	2026-02-20	—
AUPHAurinia Pharmaceuticals Inc.	Tax $644.1K · 40,385 sh	2026-01-02	—
AUPHAurinia Pharmaceuticals Inc.	Grant — · 48,558 sh	2026-01-02	—

AUPHGrant

2026-05-18 · Aurinia Pharmaceuticals Inc.

115,541

—

AUPHTax

2026-03-02 · Aurinia Pharmaceuticals Inc.

$519.0K

—

AUPHGrant

2026-02-27 · Aurinia Pharmaceuticals Inc.

59,090

—

AUPHTax

2026-02-20 · Aurinia Pharmaceuticals Inc.

$498.8K

—

AUPHTax

2026-01-02 · Aurinia Pharmaceuticals Inc.

$644.1K

—

AUPHGrant

2026-01-02 · Aurinia Pharmaceuticals Inc.

48,558

—

Outcomes measure each disclosed buy against the closing price ~6 months (120 trading days) later, with the S&P 500 over the same span for context. Pre-scheduled 10b5-1 plan trades are excluded from the record. Positions are estimated from the latest reported post-transaction holdings, split-adjusted, at the latest close. Built from SEC Form 4 filings and market prices — past outcomes, not predictions or advice.